A Case of Metastatic VIPoma With Complete Response to Peptide Radionuclide Receptor Therapy

Pancreas. 2021 Apr 1;50(4):e45-e46. doi: 10.1097/MPA.0000000000001802.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Humans
  • Liver Neoplasms / radiotherapy*
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Octreotide / analogs & derivatives*
  • Octreotide / chemistry
  • Octreotide / therapeutic use
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / therapeutic use*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / radiotherapy*
  • Radiopharmaceuticals / chemistry
  • Radiopharmaceuticals / therapeutic use
  • Receptors, Peptide / chemistry*
  • Treatment Outcome
  • Vasoactive Intestinal Peptide / blood
  • Vipoma / pathology
  • Vipoma / radiotherapy*

Substances

  • Organometallic Compounds
  • Radiopharmaceuticals
  • Receptors, Peptide
  • Vasoactive Intestinal Peptide
  • lutetium Lu 177 dotatate
  • Octreotide